Innovative immunotherapy shows promise in early clinical trial for breast cancer
A groundbreaking phase one clinical trial explored a novel cell-based immunotherapy for breast cancer. The study focuses on a new treatment approach that aims to harness the body's immune system to enhance patient responses and reduce the need for conventional chemotherapy and its associated toxicities. The trial involved 12 patients with locally advanced stage I-III HER2 breast cancer.
admin
0
1
A groundbreaking phase one clinical trial explored a novel cell-based immunotherapy for breast cancer. The study focuses on a new treatment approach that aims to harness the body's immune system to enhance patient responses and reduce the need for conventional chemotherapy and its associated toxicities. The trial involved 12 patients with locally advanced stage I-III HER2 breast cancer.
